Skip to content
  1. Committee Activity
  2. Hearings
Full Committee

BioShield II: Responding to An Ever Changing Threat

Type: Full Committee Hearing
Date:
Time: 10:00am
Location: SH 216

Member Statements

Panel I

  • Christine Grant

    Vice President, Government Relations, Aventis
    Download Testimony

  • Alan P. Timmins

    Chief Executive Officer, AVI BioPharma
    Download Testimony

  • Kathleen Jaeger

    President and CEO
    Generic Pharmaceutical Association (GPhA)
    Download Testimony

  • Carlos Angulo

    Partner, Zuckerman Spaeder, LLP
    Representing the Coalition for a Competitive Pharmaceutical Market
    Download Testimony

  • John Bartlett, M.D.

    Chief, Division of Infectious Diseases, Johns Hopkins University School of Medicine
    Representing the Infectious Disease Society of America (IDSA)
    Download Testimony

Panel II